BOSTON, Mass. and GENEVA, Switzerland – PHT Corporation is expanding its suite of patient-centric apps for improved clinical research. PHT announced the availability of Patient Connect™ Engagement Suite of apps, an integrated set of patient tools now available as part of the PHT electronic clinical outcome assessment (eCOA) System. Pharmaceutical companies and CROs have leveraged the PHT eCOA System in 750+ trials resulting in over 21 regulatory approvals.
Watch a brief demo of the Patient Connect Engagement Suite: http://bit.ly/PHTPatientConnect
75% of 400 leading pharmas and CROs surveyed by eyeforpharma.com cited the “patient” as an organizational priority in 2015. The cost to recruit and enroll patients and dropout rates continue to rise. The Patient Connect Suite helps increase protocol compliance and prevent patient dropouts by improving the patients experience in clinical research. Participation in a study is easier, more engaging and more convenient with this educational and supportive app that can include SMS messaging and access to the patient’s own study data via the StudyWorks™ Patient Portal. Valuable features and communications tools include:
Sheila Rocchio MBA, PHT Vice President of Marketing and Corporate Strategy, explained, “The development of the Engagement Suite exemplifies the continued innovation at PHT to improve the patient experience during a clinical trial. PHT is adding more services and capabilities trial sponsors are requesting to make it easier and more convenient for patients to participate in studies.”
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.